Correlation Between Coherus BioSciences and Applied Therapeutics

Can any of the company-specific risk be diversified away by investing in both Coherus BioSciences and Applied Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Coherus BioSciences and Applied Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Coherus BioSciences and Applied Therapeutics, you can compare the effects of market volatilities on Coherus BioSciences and Applied Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Coherus BioSciences with a short position of Applied Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Coherus BioSciences and Applied Therapeutics.

Diversification Opportunities for Coherus BioSciences and Applied Therapeutics

0.84

Correlation Coefficient

Coherus BioSciences  Applied Therapeutics

Very poor diversification

The 3 months correlation between Coherus and Applied is 0.84. Overlapping area represents the amount of risk that can be diversified away by holding Coherus BioSciences and Applied Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Applied Therapeutics and Coherus BioSciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Coherus BioSciences are associated (or correlated) with Applied Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Applied Therapeutics has no effect on the direction of Coherus BioSciences i.e., Coherus BioSciences and Applied Therapeutics go up and down completely randomly.

Pair Corralation between Coherus BioSciences and Applied Therapeutics

Given the investment horizon of 90 days Coherus BioSciences is expected to under-perform the Applied Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Coherus BioSciences is 1.09 times less risky than Applied Therapeutics. The stock trades about -0.15 of its potential returns per unit of risk. The Applied Therapeutics is currently generating about -0.1 of returns per unit of risk over similar time horizon. If you would invest  82.00  in Applied Therapeutics on December 29, 2024 and sell it today you would lose (30.00) from holding Applied Therapeutics or give up 36.59% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	100.0%
Values	Daily Returns

Coherus BioSciences  vs.  Applied Therapeutics

Coherus BioSciences

Risk-Adjusted Performance

Very Weak

Over the last 90 days Coherus BioSciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Applied Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Applied Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's essential indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with Coherus BioSciences and Applied Therapeutics

The main advantage of trading using opposite Coherus BioSciences and Applied Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Coherus BioSciences position performs unexpectedly, Applied Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Applied Therapeutics will offset losses from the drop in Applied Therapeutics' long position.

The idea behind Coherus BioSciences and Applied Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.